Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 11/01/2001
Publisher: CLSI
File Format: PDF
$122.00$245.21
Published:01/11/2001
Pages:16
This document provides general guidelines for performing the fibrinogen assay in the clinical laboratory. It also includes reporting of results and in vivo and in vitro conditions that may alter results. (See related publication H21-A3 in this section.)
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Human Genetic and Genomic Testing Using Traditional and High-Throughput Nucleic Acid Sequencing Methods, MM09Ed3E
$100.00 $200.00
Evaluation of Qualitative, Binary Output Examination Performance, 3rd Edition, EP12Ed3E
$90.00 $180.00
Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition
Newborn Screening Follow-up; Approved Guideline - Third Edition, NBS02Ed3E
